Riskpilot← Back to searchSign inGet full accessREISA DYREKLINIKK AS
ASActiveOrg 915195423Hovedvegen 8, 9151 StorslettVeterinary activities · NACE 7500Est. 20156 employees
Revenue 2024
NOK 9,4M
+12% vs 2023
EBITDA margin
4.0%
-35% vs 2023
Equity ratio
19.4%
Financial strength
Net profit 2024
NOK -18K
-114% vs 2023
| Revenue | NOK 9,4M | +12% |
| EBITDA | NOK 373K | -35% |
| Net profit | NOK -18K | -114% |
| Total assets | NOK 4,6M | -7% |
| Equity | NOK 886K | -2% |
| Employees | 6 | — |
Legal name
REISA DYREKLINIKK AS
Org number
915195423
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
7. april 2015
Share capital
NOK 920 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Salg av veterinærartikler, dyrefòr og dyreutstyr. I tillegg andre produkter/tjenester som naturlig hører til dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak. Selskapet kan også drive med kjøp/drift av fast eiendom.
Address
Hovedvegen 8, 9151 Storslett
Phone
+4777765122
Email
vet.nordtroms@ntvet.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 915 | 7 402 | 7 741 | 8 339 | 9 367 |
| Staff expenses | −1 125 | −1 724 | −1 698 | −1 724 | −1 947 |
| EBITDA | −239 | 568 | 744 | 575 | 373 |
| Depreciation & amort. | −135 | −193 | −189 | −199 | −185 |
| EBIT | −374 | 375 | 555 | 376 | 188 |
| Net financials | −140 | −154 | −173 | −181 | −185 |
| Profit before tax | −514 | 220 | 382 | 196 | 3 |
| Tax | −0 | −0 | −0 | 66 | 21 |
| Net profit | −514 | 220 | 382 | 130 | −18 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 729 | 4 388 | 4 505 | 4 943 | 4 577 |
| Equity | 171 | 392 | 774 | 904 | 886 |
| Long-term debt | 2 771 | 2 993 | 2 817 | 2 654 | 2 390 |
| Short-term debt | 1 787 | 1 004 | 915 | 1 385 | 1 300 |
| Total debt | 4 558 | 3 997 | 3 732 | 4 039 | 3 691 |
EBITDA margin
4.0%
This company
15.8%
Market median
-75% vs market
20202024
Equity ratio
19.4%
This company
38.2%
Market median
-49% vs market
20202024
Return on equity
-2.0%
This company
18.4%
Market median
-111% vs market
20202024
Net profit margin
-0.2%
This company
8.1%
Market median
-102% vs market
20202024
Asset turnover
2.05×
This company
1.12×
Market median
+83% vs market
20202024
Debt / equity
4.17×
This company
0.62×
Market median
-573% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MS Chief Executive Officer | Chief Executive Officer | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2019 | |
| Chairman | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Veterinær Stine Bjerke As
REISA DYREKLINIKK AS Board members of REISA DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Malén Sofie Næss | Chief Executive Officer | 0 companies |
| Stine Bjerke Solstad | Board of Directors | 0 companies |
| Kristin Hauge | Chairman | 0 companies |